nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

09.08.2023 | Letter to the Editor

Letter to the Editor: The theoretical challenges of routinely using [¹⁸F]FDG PET/MRI combined with chest HRCT for early cancer detection in asymptomatic patients

verfasst von: Paulo Schiavom Duarte

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 13/2023

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Peng L, Liao Y, Zhou R, Zhong Y, Jiang H, Wang J, et al. [F]FDG PET/MRI combined with chest HRCT in early cancer detection: a retrospective study of 3020 asymptomatic subjects. Eur J Nucl Med Mol Imaging. 2023. https://doi.org/10.1007/s00259-023-06273-6.CrossRefPubMedPubMedCentral

Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ. 2018;190:E422–9.CrossRefPubMedPubMedCentral

Wilson JMG, Jungner G, World Health Organization. Principles and practice of screening for disease. 1968. https://apps.who.int/iris/handle/10665/37650. Accessed 19 Jul 2023.

Lin JS, Bowles EJA, Williams SB, Morrison CC. Screening for thyroid cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017;317:1888–903.CrossRefPubMed

US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, et al. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:962–70.CrossRef

Nelson HD, Cantor A, Humphrey L, Fu R, Pappas M, Daeges M, et al. Screening for breast cancer. 2016. https://www.ncbi.nlm.nih.gov/books/NBK343819/. Acessed 19 Jul 2023.

US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:1965–77.CrossRef

Minamimoto R, Senda M, Jinnouchi S, Terauchi T, Yoshida T, Murano T, et al. The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006–2009) nationwide survey. Ann Nucl Med. 2013;27:46–57.CrossRefPubMed

Minamimoto R, Senda M, Uno K, Jinnouchi S, Iinuma T, Ito K, et al. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey. Ann Nucl Med. 2007;21:481–98.CrossRefPubMed

10.

Kojima S, Zhou B, Teramukai S, Hara A, Kosaka N, Matsuo Y, et al. Cancer screening of healthy volunteers using whole-body 18F-FDG-PET scans: the Nishidai clinic study. Eur J Cancer. 2007;43:1842–8.CrossRefPubMed

Titel: Letter to the Editor: The theoretical challenges of routinely using [18F]FDG PET/MRI combined with chest HRCT for early cancer detection in asymptomatic patients
verfasst von: Paulo Schiavom Duarte
Publikationsdatum: 09.08.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 13/2023
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-023-06376-0

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Letter to the Editor: The theoretical challenges of routinely using [¹⁸F]FDG PET/MRI combined with chest HRCT for early cancer detection in asymptomatic patients

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 13/2023

Correction to: Highlights of the 35th EANM Annual Congress 2022, onsite edition in Barcelona, Spain: “FROM BARCELONA WITH LOVE”

Feasibility of [18F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study

Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor

Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET

Aging imaging: the future demand of health management

One stop non-invasive identification of culprit vessels and related ischemia in coronary artery bypass patient using combined 82Rubidium PET/coronary CT angiography